Repair of Damaged Pancreatic β Cells: New Hope for a Type 2 Diabetes Reversal?
作者信息
Wang Zhili, Xiong Haiyan, Ren Tu Ya Sa
机构信息
Beijing Chaoyang Diabetes Hospital, Beijing 100025, China.
出版信息
J Transl Int Med. 2021 Sep 28;9(3):150-151. doi: 10.2478/jtim-2021-0037. eCollection 2021 Sep.
Abstract
摘要
相似文献
1
Repair of Damaged Pancreatic β Cells: New Hope for a Type 2 Diabetes Reversal?
J Transl Int Med. 2021 Sep 28;9(3):150-151. doi: 10.2478/jtim-2021-0037. eCollection 2021 Sep.
2
Efficient β-cell regeneration by a combination of neogenesis and replication following β-cell ablation and reversal of pancreatic duct ligation.
Stem Cells. 2013 Nov;31(11):2388-95. doi: 10.1002/stem.1492.
3
Recovery from overt type 1 diabetes ensues when immune tolerance and β-cell formation are coupled with regeneration of endothelial cells in the pancreatic islets.
Diabetes. 2013 Aug;62(8):2879-89. doi: 10.2337/db12-1281. Epub 2013 May 28.
4
Migration path of stem cells involved in the repair of damaged pancreatic tissue caused by pancreatitis.
Int J Clin Exp Pathol. 2014 Apr 15;7(5):2438-45. eCollection 2014.
5
Mesenchymal stem cells and differentiated insulin producing cells are new horizons for pancreatic regeneration in type I diabetes mellitus.
Int J Biochem Cell Biol. 2017 Jun;87:77-85. doi: 10.1016/j.biocel.2017.03.018. Epub 2017 Apr 3.
6
Anti-TCR therapy combined with fingolimod for reversal of diabetic hyperglycemia by β cell regeneration in the LEW.1AR1-iddm rat model of type 1 diabetes.
J Mol Med (Berl). 2014 Jul;92(7):743-55. doi: 10.1007/s00109-014-1137-2. Epub 2014 Mar 7.
7
Hope and fear for new classes of type 2 diabetes drugs: is there preclinical evidence that incretin-based therapies alter pancreatic morphology?
J Endocrinol. 2014 Mar 7;221(1):T43-61. doi: 10.1530/JOE-13-0577. Print 2014 Apr.
8
The STING-IRF3 pathway is involved in lipotoxic injury of pancreatic β cells in type 2 diabetes.
Mol Cell Endocrinol. 2020 Dec 1;518:110890. doi: 10.1016/j.mce.2020.110890. Epub 2020 Aug 8.
9
Sirtuin 6 regulates glucose-stimulated insulin secretion in mouse pancreatic beta cells.
Diabetologia. 2016 Jan;59(1):151-160. doi: 10.1007/s00125-015-3778-2.
10
Global gene expression profiling of pancreatic islets in mice during streptozotocin-induced β-cell damage and pancreatic Glp-1 gene therapy.
Dis Model Mech. 2013 Sep;6(5):1236-45. doi: 10.1242/dmm.012591. Epub 2013 Jul 4.
引用本文的文献
1
Altered Autonomic Function in Metabolic Syndrome: Interactive Effects of Multiple Components.
J Clin Med. 2024 Feb 3;13(3):895. doi: 10.3390/jcm13030895.
2
Gas chromatography-mass spectrometry pilot study to identify volatile organic compound biomarkers of childhood obesity with dyslipidemia in exhaled breath.
J Transl Int Med. 2023 Mar 28;11(1):81-89. doi: 10.2478/jtim-2022-0035. eCollection 2023 Mar.
3
A Comprehensive Weighted Gene Co-expression Network Analysis Uncovers Potential Targets in Diabetic Kidney Disease.
J Transl Int Med. 2023 Jan 13;10(4):359-368. doi: 10.2478/jtim-2022-0053. eCollection 2022 Dec.
4
Exploring the Implications of New-Onset Diabetes in COVID-19: A Narrative Review.
Cureus. 2023 Jan 3;15(1):e33319. doi: 10.7759/cureus.33319. eCollection 2023 Jan.
5
PDX-1: A Promising Therapeutic Target to Reverse Diabetes.
Biomolecules. 2022 Nov 30;12(12):1785. doi: 10.3390/biom12121785.
6
Polymorphisms in glucose homeostasis genes are associated with cardiovascular and renal parameters in patients with diabetic nephropathy.
Ann Med. 2022 Dec;54(1):3039-3051. doi: 10.1080/07853890.2022.2138531.
7
Multidisciplinary Progress in Obesity Research.
Genes (Basel). 2022 Sep 30;13(10):1772. doi: 10.3390/genes13101772.
8
lncRNA ZFAS1 Positively Facilitates Endothelial Ferroptosis via miR-7-5p/ACSL4 Axis in Diabetic Retinopathy.
Oxid Med Cell Longev. 2022 Aug 31;2022:9004738. doi: 10.1155/2022/9004738. eCollection 2022.
本文引用的文献
1
A Brief Review of the Mechanisms of β-Cell Dedifferentiation in Type 2 Diabetes.
Nutrients. 2021 May 10;13(5):1593. doi: 10.3390/nu13051593.
2
Beta cell dysfunction in diabetes: the islet microenvironment as an unusual suspect.
Diabetologia. 2020 Oct;63(10):2076-2085. doi: 10.1007/s00125-020-05186-5. Epub 2020 Sep 7.
3
Effect of short-term intensive insulin therapy on α-cell function in patients with newly diagnosed type 2 diabetes.
Medicine (Baltimore). 2020 Apr;99(14):e19685. doi: 10.1097/MD.0000000000019685.
4
Reply to "Utility of Unrefined Carbohydrates in Type 2 Diabetes. Comment on Reversing Type 2 Diabetes: A Narrative Review of the Evidence, , 2019, , 766".
Nutrients. 2019 Jul 18;11(7):1644. doi: 10.3390/nu11071644.
5
Understanding the mechanisms of reversal of type 2 diabetes.
Lancet Diabetes Endocrinol. 2019 Sep;7(9):726-736. doi: 10.1016/S2213-8587(19)30076-2. Epub 2019 May 13.
6
Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study.
Lancet Diabetes Endocrinol. 2019 Jun;7(6):452-461. doi: 10.1016/S2213-8587(19)30093-2. Epub 2019 Apr 26.
7
Insulin Action Research and the Future of Diabetes Treatment: The 2017 Banting Medal for Scientific Achievement Lecture.
Diabetes. 2018 Sep;67(9):1701-1709. doi: 10.2337/dbi18-0025.
8
Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis.
Lancet Diabetes Endocrinol. 2013 Sep;1(1):28-34. doi: 10.1016/S2213-8587(13)70006-8. Epub 2013 Feb 4.
9
Islet microvasculature in islet hyperplasia and failure in a model of type 2 diabetes.
Diabetes. 2006 Nov;55(11):2965-73. doi: 10.2337/db06-0733.
10
UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
Diabet Med. 1998 Apr;15(4):297-303. doi: 10.1002/(SICI)1096-9136(199804)15:4<297::AID-DIA572>3.0.CO;2-W.
Zotero 插件